| __timestamp | Regeneron Pharmaceuticals, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 1271353000 | 855506000 |
| Thursday, January 1, 2015 | 1620577000 | 996170000 |
| Friday, January 1, 2016 | 2052295000 | 1047690000 |
| Sunday, January 1, 2017 | 2075142000 | 1324625000 |
| Monday, January 1, 2018 | 2186100000 | 1416476000 |
| Tuesday, January 1, 2019 | 3036600000 | 1754540000 |
| Wednesday, January 1, 2020 | 2735000000 | 1829537000 |
| Friday, January 1, 2021 | 2908100000 | 3051100000 |
| Saturday, January 1, 2022 | 3592500000 | 2540300000 |
| Sunday, January 1, 2023 | 4439000000 | 3162900000 |
| Monday, January 1, 2024 | 5132000000 | 3630300000 |
In pursuit of knowledge
In the competitive landscape of biopharmaceuticals, research and development (R&D) investments are pivotal for innovation and growth. Over the past decade, Vertex Pharmaceuticals Incorporated and Regeneron Pharmaceuticals, Inc. have been at the forefront of this race. From 2014 to 2023, Regeneron consistently outpaced Vertex in R&D spending, with a notable 250% increase, peaking at $4.4 billion in 2023. Vertex, while trailing, demonstrated a robust growth trajectory, with a 270% rise, reaching $3.2 billion in the same year. This trend underscores the strategic emphasis both companies place on pioneering new therapies and maintaining competitive edges. As the biopharma industry continues to evolve, these investments highlight the relentless pursuit of innovation, promising groundbreaking treatments and enhanced patient outcomes.
R&D Insights: How Sanofi and Regeneron Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Vertex Pharmaceuticals Incorporated and Viatris Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Exelixis, Inc.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Vertex Pharmaceuticals Incorporated vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Vertex Pharmaceuticals Incorporated and Novavax, Inc.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alpine Immune Sciences, Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs CRISPR Therapeutics AG
Regeneron Pharmaceuticals, Inc. or Bausch Health Companies Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and HUTCHMED (China) Limited
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and Xencor, Inc.